UnitedHealth Group (UNH) to Post Earnings on Thursday

Key Points

• UnitedHealth Group is expected to report Q2 2026 earnings before the market opens on Thursday, July 16, with analysts forecasting $4.84 per share on $110.76 billion in revenue.
• The company’s latest quarter showed solid performance, as it beat earnings and revenue estimates with $7.23 EPS and $111.65 billion in revenue, while analysts still see about $18 EPS for FY 2026 and $21 EPS for next year.
• Investor sentiment is being shaped by several recent developments, including a higher quarterly dividend of $2.32 and news that UnitedHealth is investing nearly $1.5 billion in AI and facing ongoing regulatory and legal scrutiny over Medicare and pharmacy-related issues.

UnitedHealth Group (NYSE:UNH - Get Free Report) is anticipated to announce its Q2 2026 results before the market opens on Thursday, July 16th. Analysts expect UnitedHealth Group to post earnings of $4.84 per share and revenue of $110.7611 billion for the quarter. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Individuals can check the company's upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Thursday, July 16, 2026 at 8:00 AM ET.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.76 by $0.47. The firm had revenue of $111.65 billion for the quarter, compared to analyst estimates of $109.84 billion. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The company's revenue was up 2.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $7.20 earnings per share. On average, analysts expect UnitedHealth Group to post $18 EPS for the current fiscal year and $21 EPS for the next fiscal year.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $425.61 on Thursday. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.69. UnitedHealth Group has a 52 week low of $234.60 and a 52 week high of $430.77. The firm has a 50 day moving average of $397.02 and a 200-day moving average of $337.55. The company has a market cap of $386.52 billion, a price-to-earnings ratio of 32.15, a price-to-earnings-growth ratio of 1.72 and a beta of 0.62.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th were paid a $2.32 dividend. This represents a $9.28 annualized dividend and a yield of 2.2%. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.21. The ex-dividend date of this dividend was Monday, June 15th. UnitedHealth Group's payout ratio is presently 70.09%.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 800 shares of the business's stock in a transaction dated Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total transaction of $284,000.00. Following the transaction, the chief executive officer directly owned 17,805 shares in the company, valued at approximately $6,320,775. The trade was a 4.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.28% of the stock is owned by insiders.

Institutional Trading of UnitedHealth Group

A number of institutional investors and hedge funds have recently modified their holdings of the business. Sunbelt Securities Inc. boosted its position in UnitedHealth Group by 4.9% in the fourth quarter. Sunbelt Securities Inc. now owns 1,416 shares of the healthcare conglomerate's stock worth $467,000 after purchasing an additional 66 shares during the last quarter. Mcguire Capital Advisors Inc. bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $40,000. Compound Planning Inc. increased its holdings in UnitedHealth Group by 10.5% during the fourth quarter. Compound Planning Inc. now owns 9,744 shares of the healthcare conglomerate's stock worth $3,217,000 after buying an additional 927 shares during the last quarter. Axxcess Wealth Management LLC boosted its stake in UnitedHealth Group by 3.3% in the fourth quarter. Axxcess Wealth Management LLC now owns 18,902 shares of the healthcare conglomerate's stock valued at $6,240,000 after acquiring an additional 611 shares during the last quarter. Finally, Corient Private Wealth LLC increased its stake in shares of UnitedHealth Group by 4.8% during the 4th quarter. Corient Private Wealth LLC now owns 431,657 shares of the healthcare conglomerate's stock worth $142,494,000 after purchasing an additional 19,606 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth said an external audit found nearly 97% of diagnoses in its HouseCalls home-visit unit were supported by patient medical records, which could help ease concerns about Medicare billing practices and reduce regulatory overhang. Reuters article
• Positive Sentiment: UnitedHealth is investing nearly $1.5 billion in AI for 2026 to expand automation and digital tools, which investors may view as a way to support efficiency and longer-term growth beyond cost savings. Yahoo Finance article
• Positive Sentiment: The company’s push to prioritize profitability over rapid growth, along with Optum expansion and improving margins, is being framed as a potential long-term turnaround catalyst. Yahoo Finance article
• Positive Sentiment: UnitedHealth also expanded coverage of Guardant Health’s Shield blood test for colorectal cancer screening, reinforcing its role in supporting emerging preventive-care tools. Yahoo Finance article
• Neutral Sentiment: Commentary highlighting healthcare-sector strength and a 12.41% rise in a major healthcare ETF may support sentiment for UNH, but it does not specifically change the company’s fundamentals. ETF Trends article
• Neutral Sentiment: Recent articles noting that UNH rebounded sharply in the first half and may still be undervalued suggest investors remain focused on the turnaround, though the pieces are largely opinion-based. Motley Fool article
• Negative Sentiment: New criticism from a Motley Fool piece argues that UnitedHealth may not be the best healthcare investment, which could weigh on sentiment even if it is not tied to a new company event. Motley Fool article
• Negative Sentiment: UnitedHealth and other insurers are suing states over laws targeting pharmacy businesses, and that legal fight may keep regulatory risk in focus for investors. New York Times article

Analyst Upgrades and Downgrades

UNH has been the topic of a number of research analyst reports. Erste Group Bank raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Monday, April 27th. Mizuho increased their price target on UnitedHealth Group from $440.00 to $460.00 and gave the stock an "outperform" rating in a report on Monday, June 8th. Barclays boosted their price objective on UnitedHealth Group from $373.00 to $429.00 and gave the company an "overweight" rating in a report on Tuesday, May 26th. Truist Financial increased their target price on UnitedHealth Group from $395.00 to $440.00 and gave the stock a "buy" rating in a report on Monday, June 1st. Finally, Raymond James Financial upgraded shares of UnitedHealth Group from a "market perform" rating to an "outperform" rating and set a $330.00 price objective on the stock in a report on Wednesday, April 1st. One research analyst has rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, UnitedHealth Group has an average rating of "Moderate Buy" and an average target price of $414.75.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.